12. Top R&D Spenders of 2013



  • #20. Merck KGaA

    2013 R&D spending: $1.638 billion (€1.183 billion)1
    2012 R&D spending: $1.644 billion (€1.187 billion)1
    % Change: -0.3%
  • #19. Astellas Pharma

    2013 R&D spending: $1.771 billion (¥182.000 billion)
    2012 R&D spending: $1.846 billion (¥189.800 billion)
    % Change: -4.1%
  • #18. Daiichi Sankyo

    2013 R&D spending: $1.777 billion (¥183.047 billion)
    2012 R&D spending: $1.796 billion (¥185.052 billion)
    % Change: -1.1%
  • #17. Gilead Sciences

    2013 R&D spending: $2.120 billion
    2012 R&D spending: $1.760 billion
    % Change: 20.5%
  • #16. Novo Nordisk

    2013 R&D spending: $2.178 billion (DKK 11.733 billion)
    2012 R&D spending: $2.023 billion (DKK 10.897 billion)
    % Change: 7.7% 
  • #15. Celgene

    2013 R&D spending: $2.226 billion
    2012 R&D spending: $1.724 billion
    % Change: 29.1%
  • #14. Bayer

    2013: R&D spending: $2.291 billion (€1.654 billion)2
    2012: R&D spending: $2.162 billion (€1.561 billion)2
    % Change: 6.0%
  • #13. AbbVie3

    2013 R&D spending: $2.855 billion3
    2012 R&D spending: $2.778 billion3
    % Change: 2.8%
  • #12. Takeda Pharmaceutical

    2013 R&D spending: $3.148 billion (¥324.292 billion)
    2012 R&D spending: $2.737 billion (¥281.885 billion)
    % Change: 15.0%
  • #11. Bristol-Myers Squibb

    2013 R&D spending: $3.731 billion
    2012 R&D spending: $3.904 billion
    % Change: -4.4%
    • #10. Amgen

      2013 R&D spending: $3.929 billion
      2012 R&D spending: $3.296 billion
      % Change: 19.2%
    • #9. AstraZeneca

      2013 R&D spending: $4.821 billion
      2012 R&D spending: $5.243 billion4
      % Change: 13.7%
    • #8. Eli Lilly

      2013 R&D spending: $5.531 billion
      2012 R&D spending: $5.278 billion
      % Change: 4.8%
    • #7. GlaxoSmithKline

      2013 R&D spending: $6.518 billion (£3.923 billion)
      2012 R&D spending: $6.611 billion (£3.979 billion)5
      % Change: -1.4%
    • #6. Sanofi

      2013 R&D spending: $6.608 billion (€4.770 billion)
      2012 R&D spending: $6.818 billion (€4.922 billion)
      % Change: -3.1%
    • #5. Pfizer

      2013 R&D spending: $6.678 billion
      2012 R&D spending: $7.482 billion6
      % Change: -10.7%
    • #4. Merck & Co.

      2013 R&D spending: $7.503 billion
      2012 R&D spending: $8.168 billion
      % Change: -8.1%
    • #3. Johnson & Johnson

      2013 R&D spending: $8.183 billion
      2012 R&D spending: $7.665 billion
      % Change: 6.8%
    • #2. Novartis

      2013 R&D spending: $9.852 billion
      2012 R&D spending: $9.332 billion
      % Change: 5.6%
    • #1. Roche

      2013 R&D spending: $9.910 billion (CHF 8.700 billion)
      2012 R&D spending: $9.654 billion (CHF 8.475 billion)
      % Change: 2.7%
Post a Comment